必来松（丙氧苯氮酮）治疗类风湿性关节炎的疗效及耐受性（作者译）
[Effect and tolerance of Biarison (proquazone) in rheumatoid arthritis (author's transl)].
作者信息
Ghimicescu R
出版信息
MMW Munch Med Wochenschr. 1978 Jun 30;120(26):901-4.
PMID:307165
Abstract
Biarison was tested in 24 patients mainly with classical rheumatoid arthritis for its efficacy and tolerance. There was a distinct improvement in the course of the 4 weeks' therapy with a mean dosage of 900 mg/day (it was in the meantime raised to a maximum of 1500 mg/day in isolated cases) especially in the pain, stiffness and functional capacity. Biarison caused few gastrointestinal side effects: the tolerance may be said to be good on the whole.
摘要
对24名主要患有典型类风湿性关节炎的患者进行了比阿瑞生（Biarison）的疗效和耐受性测试。在平均日剂量为900毫克（个别情况下最高增至1500毫克/天）的4周治疗过程中，病情有明显改善，尤其是在疼痛、僵硬和功能能力方面。比阿瑞生引起的胃肠道副作用较少：总体而言耐受性良好。
相似文献
1
[Effect and tolerance of Biarison (proquazone) in rheumatoid arthritis (author's transl)].必来松（丙氧苯氮酮）治疗类风湿性关节炎的疗效及耐受性（作者译）
MMW Munch Med Wochenschr. 1978 Jun 30;120(26):901-4.
2
[Treatment of rheumatoid arthritis with biarison. Results of a double-blind study with placebo (author's transl)].[使用比亚瑞松治疗类风湿性关节炎。安慰剂双盲研究结果（作者译）]
Med Klin. 1978 Oct 27;73(43):1517-22.
3
[Determination of efficacy of proquazone in chronic rheumatoid arthritis].
Ryumachi. 1982 Jun;22(3):275-83.
4
[Results of a long-term study with acemetacin in the therapy of patients suffering from rheumatoid arthritis (author's transl)].
Arzneimittelforschung. 1980;30(8A):1460-3.
5
Proquazone ('Biarison') in osteoarthritis of the knee: a double-blind, dose comparison trial.丙氧苯宗（“Biarison”）治疗膝骨关节炎：一项双盲剂量对比试验。
Pharmatherapeutica. 1980;2(5):323-9.
6
A long-term double-blind comparative study on proquazone (Biarison) and ibuprofen in rheumatoid arthritis.丙氧苯唑（Biarison）与布洛芬治疗类风湿性关节炎的长期双盲对比研究。
Scand J Rheumatol Suppl. 1978(21):28-32. doi: 10.3109/03009747809095672.
7
8
[Analgesic and anti-inflammatory efficacy of biarison. Clinical experimental studies (author's transl)].比亚里松的镇痛与抗炎疗效。临床实验研究（作者译）
MMW Munch Med Wochenschr. 1978 Mar 10;120(10):331-4.
9
[Preliminary results with a new non-steroidal antirheumatic drug (author's transl)].一种新型非甾体类抗风湿药物的初步研究结果（作者译）
Wien Klin Wochenschr. 1975 Jun 27;87(13):427.
10
A double-blind randomised controlled trial of droxicam versus indomethacin in rheumatoid arthritis.
Eur J Rheumatol Inflamm. 1991;11(4):15-20.
引用本文的文献
1
Proquazone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases and pain states.普罗喹宗。对其药效学、药代动力学特性以及在风湿性疾病和疼痛状态下的治疗效果的综述。
Drugs. 1987 May;33(5):478-502. doi: 10.2165/00003495-198733050-00004.
Zotero 插件